Inventor · disambiguated record
Petra Reinke
Also filed as: REINKE PETRA
8 granted patents·5 pending applications·84 citations·filing 2000–2022
84Inventor score
Files withUNIV BERLIN CHARITE5KERN FLORIAN3CHARITE UNIVERSIT UMLAUT OVER1EDWARDS LIFESCIENCES CORP1KLEIN FRANK1
Top patents by PatentIndex Score
13 records- 0188US7718425B2Use of a B-cell-depleting antibody for treatment of polyoma virus infectionsCHARITE UNIVERSIT UMLAUT OVER·Filed 2007·Granted May 18, 2010·48 cites·22 claims
- 0278US7041442B1Peptides for vaccinating against human CMVKERN FLORIAN·Filed 2000·Granted May 9, 2006·19 cites·8 claims
- 0373US7022322B2treatment of cardiomyopathy by removal of autoantibodiesEDWARDS LIFESCIENCES CORP·Filed 2002·Granted Apr 4, 2006·9 cites·5 claims
- 0469US9763985B2Antigen-specific central-memory T cell preparations having high CD4+ fractionVOLK HANS-DIETER·Filed 2012·Granted Sep 19, 2017·1 cites·8 claims
- 0561US7994096B2Method for antigen-specific stimulation of T lymphocytes with synthetic peptide librariesKERN FLORIAN·Filed 2001·Granted Aug 9, 2011·7 cites·13 claims
- 0657US2023406903A1Reprogramming immune cells by targeted integration of zeta-deficient chimeric antigen receptor transgenesUNIV BERLIN CHARITE·Filed 2021·Application pending·0 cites
- 0756US2024066061A1A cxcr3+ cell or cell preparation for use in cancer treatmentUNIV BERLIN CHARITE·Filed 2022·Application pending·0 cites
- 0852US2023174936A1Immunosuppressant-resistant t-cells for adoptive immunotherapyUNIV BERLIN CHARITE·Filed 2021·Application pending·0 cites
- 0949US8617560B2Peptides for vaccination against human CMVKERN FLORIAN·Filed 2006·Granted Dec 31, 2013·0 cites·19 claims
- 1049US2021364495A1Crispr associated protein reactive t cell immunityUNIV BERLIN CHARITE·Filed 2020·Application pending·0 cites
- 1137US9726660B2Method and kit for testing various selected materials and/or surface structures for culturing cellsKLEIN FRANK·Filed 2010·Granted Aug 8, 2017·0 cites·11 claims
- 1234US2020018748A1Urine flow cytometry as biomarker of renal diseasesUNIV BERLIN CHARITE·Filed 2018·Application pending·0 cites
- 1325US10144777B2B-lymphocyte targeting agents for use in a method for the treatment of a diseaseTSCHOEPE CARSTEN·Filed 2010·Granted Dec 4, 2018·0 cites·21 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →